Assessment of Iron Overload in Very Young Children with Limited Thalassemia Care Resources in South China

References

• Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–1146
   PubMed Web of Science ®Google Scholar
• Delea TE, Edelsberg J, Sofrygin O, et al. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion. 2007;47(10):1919–1929
   PubMed Web of Science ®Google Scholar
• Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med. 1994;331(9):574–578
   PubMed Web of Science ®Google Scholar
• Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006;107(9):3436–3441
   PubMed Web of Science ®Google Scholar
• Telfer P, Coen PG, Christou S, et al. Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Haematologica. 2006;91(9):1187–1192
   PubMed Web of Science ®Google Scholar
• Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10(1):42–46
   PubMedGoogle Scholar
• Kontoghiorghes GJ. The proceedings of the 17th International Conference on Chelation: application of effective chelation therapies in iron loading and non iron loading conditions, and the gap in the prevention and treatment policies on thalassemia between developed and developing countries. Hemoglobin. 2009;33(5):283–286
   Google Scholar
• Weatherall DJ. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol. 2011;154(2):736–744
   Google Scholar
• Li CG, Li CF, Li Q, Li M. Thalassemia incidence and treatment in China with special reference to Shenzhen City and Guangdong Province. Hemoglobin. 2009;33(5):296–303
   PubMed Web of Science ®Google Scholar
• Liu S, Griffiths SM. From economic development to public health improvement: China faces equity challenges. Public Health. 2011;125(10):669–674
   PubMed Web of Science ®Google Scholar
• Hutubessy RC, Hanvoravongchai P, Edejer TT; Asian MRI Study Group. Diffusion and utilization of magnetic resonance imaging in Asia. Int J Technol Assess Health Care. 2002;18(3):690–704
   Google Scholar
• Au WY, Lee V, Lau CW, et al. A synopsis of current care of thalassaemia major patients in Hong Kong. Hong Kong Med J. 2011;17(4):261–266
   Google Scholar
• Kirk P, He T, Anderson LJ, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging. 2010;32(2):315–319
   PubMed Web of Science ®Google Scholar
• Lam WWM, Au WY, Chu WWC, et al. One stop measurement of iron deposition in anterior pituitary, liver and heart in thalassemia patients. J Magn Reson Imaging. 2008;28(1):29–33
   Google Scholar
• Au WY, Lam WWM, Chu W, et al. A T2* magnetic resonance imaging (MRI) study of pancreatic iron overload in thalassemia major. Haematologica. 2007;93(1):116–119
   Google Scholar
• Au WY, Lam WWM, Chu WWC, et al. A cross-sectional MRI assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. Haematologica. 2008;93(5):784–786
   PubMed Web of Science ®Google Scholar
• Tanner MA, He T, Westwood MA, et al. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica. 2006;91(10):1388–1391
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004;127(3):348–355
   PubMed Web of Science ®Google Scholar
• Ghugre NR, Enriquez CM, Gonzalez I, et al. MRI detects myocardial iron in the human heart. Magn Reson Med. 2006;56(3):681–686
   Google Scholar
• Noetzli LJ, Panigrahy A, Mittelman SD, et al. Pituitary iron and volume predict hypogonadism in transfusional iron overload. Am J Hematol. 2012;87(2):167–171
   PubMed Web of Science ®Google Scholar
• Noetzli LJ, Mittelman SD, Watanabe RM, et al. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol. 2012;87(2):155–160
   PubMed Web of Science ®Google Scholar
• Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123(14):1519–1528
   PubMed Web of Science ®Google Scholar
• Lee VS, Resnick D, Bundy JM, et al. Cardiac function: MR evaluation in one breath hold with real-time true fast imaging with steady-state precession. Radiology. 2002;222(3):835–842
   PubMed Web of Science ®Google Scholar
• Peng X. China’s demographic history and future challenges. Science. 2011;333(6042):581–587
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu X, Meng Q, et al. Evaluating the financial protection of patients with chronic disease by health insurance in rural China. Int J Equity Health. 2009;8(2):42–47
   Google Scholar
• Wu KH, Chang JG, Ho YJ, et al. Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with β-thalassemia major. Hemoglobin. 2006;30(2):251–256
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171–2179
   PubMed Web of Science ®Google Scholar
• Chouliaras G, Berdoukas V, Ladis V, et al. Impact of magnetic resonance imaging on cardiac mortality in thalassemia major. J Magn Reson Imaging. 2011;34(1):56–59
   PubMed Web of Science ®Google Scholar
• Pennell DJ. T2* magnetic resonance and myocardial iron in thalassemia. Ann NY Acad Sci. 2005;1054:373–378
   PubMed Web of Science ®Google Scholar
• Yip WC, Hsiao W, Meng Q, et al. Realignment of incentives for health-care providers in China. Lancet. 2010;375(9720):1120–1130
   PubMed Web of Science ®Google Scholar
• Berdoukas V, Nord A, Carson S, et al. Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol. 2013;88(11):E283–E285
   Google Scholar
• Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in β-thalassemia major in a developing country. J Pediatr Endrocinol Metab. 2000;13(6):651–656
   Google Scholar
• De Sanctis V, Eleftheriou A, Malaventura C. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev. 2004;2(Suppl 2):249–255
   PubMedGoogle Scholar
• Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with β-thalassaemia major. Br J Haematol. 2006;134(4):438–444
   PubMed Web of Science ®Google Scholar
• Hardee K. Implications of China’s one-child policy. Int Demogr. 1984;3(5):11–12
   Google Scholar
• Viprakasit V, Lee-Lee C, Chong QT, et al. A. Iron chelation therapy in the management of thalassemia: the Asian perspectives. Int J Hematol. 2009;90(4):435–445
   PubMed Web of Science ®Google Scholar